While few details have been released, factors that could affect individual case value include the severity of the meningioma, whether surgery is required, the duration and amount of Depo-Provera use, plaintiffs age at diagnosis, medical costs, lost wages and any impact on quality of life
Protocols describe protecting from light
PIONEER 3: Head-to-head vs Januvia (sitagliptin) 1,4 Study design: 78-week, randomized, double-blind, double-dummy, active controlled, parallel-group, phase 3a trial designed to assess the efficacy and assess long-term adverse event profile of once-daily semaglutide tablets vs Januvia in addition to metformin with or without sulfonylurea
Patients who have been on the maintenance dose for at least 812 weeks without adequate appetite suppression or weight loss (less than 5% body weight reduction) should discuss their response with their prescriber, as alternative approaches may be warranted
The article groups this with other conditions that warrant careful provider evaluation instead of absolute exclusion
